| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/19/2007 | US20070166363 Use of cholinesterase inhibitors for treating vascular depression |
| 07/19/2007 | US20070166362 Transdermal and transmucosal preparations |
| 07/19/2007 | US20070166361 Formulations for transdermal or transmucosal application |
| 07/19/2007 | US20070166360 External preparation |
| 07/19/2007 | US20070166358 Nasal mucus absorber pad |
| 07/19/2007 | US20070166357 Bandage For Facilitating Transdermal Respiration And Healing |
| 07/19/2007 | US20070166352 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 07/19/2007 | US20070166336 Stable and palatable oral liquid sumatriptan compositions |
| 07/19/2007 | US20070166326 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166325 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine |
| 07/19/2007 | US20070166324 West Nile vaccine |
| 07/19/2007 | US20070166317 Microparticles |
| 07/19/2007 | US20070166298 Formulations for the rectal administration of thrombolytically-active agents |
| 07/19/2007 | US20070166285 Systems and methods related to degradation of uremic toxins |
| 07/19/2007 | US20070166263 Vesicles of high molecular weight silicone polyethers |
| 07/19/2007 | US20070166249 Pharmaceutical and cosmetic formulations for treating fingernails |
| 07/19/2007 | US20070166242 Oral care product and method for the reduction of dental caries through inclusion of mannan and galactomannan polysaccharides in dentifrice formulations |
| 07/19/2007 | US20070166241 Salicylic acid acne spray formulations and methods for treating acne with same |
| 07/19/2007 | US20070166240 0.08 mu g/mL up to 128 mu g/mL formoterol or a derivative in water that is stable during long term storage; intended for administration as a nebulized aerosol for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders |
| 07/19/2007 | US20070166239 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | US20070166238 Composition and delivery system |
| 07/19/2007 | US20070166237 Method for the treatment of bone disorders |
| 07/19/2007 | US20070166236 Formoterol or derivative in water for long term storage stability; nebulized aerosol |
| 07/19/2007 | US20070166235 Bronchodilating beta-agonist compositions and methods |
| 07/19/2007 | US20070166234 Analgesically effective amount of opioid analgesic is combined with polymer to form a matrix, contains a surfactant in sufficient amount to cause nasal irritation; dosage form is abuse deterrent |
| 07/19/2007 | US20070166233 Abuse resistant transdermal drug delivery |
| 07/19/2007 | US20070163899 Fragrance sample insert |
| 07/19/2007 | DE102006002877A1 Preparing very small organic nanoparticle, useful in, e.g. medicine, comprises mixing saturated organic solution in a solvent, e.g. methanol, for precipitating with aqueous phase, mixing the precipitate with water and non-ionic surfactant |
| 07/19/2007 | DE102006001941A1 Schichtsilicatformulierung für eine kontrollierte Wirkstofffreisetzung Schichtsilicatformulierung for controlled drug release |
| 07/19/2007 | DE102006001553A1 Teilchen mit darin enthaltener empfindlicher Komponente Particles contained therein sensitive component |
| 07/19/2007 | CA2636914A1 Oral composition containing interferon-.alpha. |
| 07/19/2007 | CA2636663A1 Solid pharmaceutical composition comprising irbesartan |
| 07/19/2007 | CA2636618A1 Oral s-adenosylmethionine compositions |
| 07/19/2007 | CA2636119A1 Bioadhesive drug formulations for oral transmucosal delivery |
| 07/19/2007 | CA2635988A1 Hemostatic textile |
| 07/19/2007 | CA2635949A1 Controlled release formulation of divalproic acid and its derivatives |
| 07/19/2007 | CA2635724A1 Thermoreversible oil-in-water emulsion |
| 07/19/2007 | CA2633581A1 Pharmaceutical composition containing omega-3 fatty acids and a silica |
| 07/19/2007 | CA2632962A1 Sustained release preparation and method for production thereof |
| 07/19/2007 | CA2627695A1 Dry formulations of aripiprazole |
| 07/19/2007 | CA2627693A1 Wet granulation pharmaceutical compositions of aripiprazole |
| 07/19/2007 | CA2601803A1 Preventive or therapeutic agent and method for immune disease |
| 07/18/2007 | EP1808438A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/18/2007 | EP1808174A1 Medicament compositions based on tiotropium salts and on salmeterol salts |
| 07/18/2007 | EP1808166A1 Amoxicillin trihydrate |
| 07/18/2007 | EP1808165A1 Dry formulations of aripiprazole |
| 07/18/2007 | EP1808164A1 Wet granulation pharmaceutical compositions of aripiprazole |
| 07/18/2007 | EP1808163A1 Compressed solid dosage forms with drugs of low solubility and process for making the same |
| 07/18/2007 | EP1808162A1 Atorvastatin pharmaceutical formulation |
| 07/18/2007 | EP1808161A1 Microprojectile delivery system and particulate product |
| 07/18/2007 | EP1808160A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/18/2007 | EP1808159A1 New pharmaceutical composition based on essential oils for a nose and/or mouth spray |
| 07/18/2007 | EP1808158A2 Presbyopia treatment by lens alteration |
| 07/18/2007 | EP1807511A2 Stable and filterable enveloped virus formulations |
| 07/18/2007 | EP1807187A1 Method for coating powders |
| 07/18/2007 | EP1807156A1 New pharmaceutical formulations useful in the treatment of insomnia |
| 07/18/2007 | EP1807149A2 Methods and devices for sustained in-vivo release of an active agent |
| 07/18/2007 | EP1807146A2 Composition for improving efficiency of drug delivery |
| 07/18/2007 | EP1807123A2 A method for improvement of tolerance for therapeutically effective agents delivered by inhalation |
| 07/18/2007 | EP1807122A1 Medicinal aerosol formulations and methods of synthesizing ingredients therefor |
| 07/18/2007 | EP1807088A1 Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives |
| 07/18/2007 | EP1807060A1 Anisometric particles in the form of nanofibers/mesofibers, nanopipes/mesopipes, nanocables/mesocables, nanobands/mesobands, and the curved or branched variations thereof |
| 07/18/2007 | EP1807059A1 Lercanidipine capsules |
| 07/18/2007 | EP1807058A1 Tablets with site time-controlled gastrointestinal release of active ingredient |
| 07/18/2007 | EP1807057A2 Aliphatic amine polymer salts for tableting |
| 07/18/2007 | EP1807056A2 Segmented device for the delayed release of molecules in a tangential direction through thin films and uses thereof |
| 07/18/2007 | EP1807055A1 Process for forming amorphous atorvastatin |
| 07/18/2007 | EP1807054A2 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
| 07/18/2007 | EP1807053A1 Liposomal formulation of bortezomib (ps-341) |
| 07/18/2007 | EP1807052A1 Liposome formulation of peptide boronic acids compounds |
| 07/18/2007 | EP1807051A2 Compositions and methods for stabilizing liposomal camptothecin formulations |
| 07/18/2007 | EP1807050A1 Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent |
| 07/18/2007 | EP1807049A1 Spontaneously dispersible pharmaceutical compositions |
| 07/18/2007 | EP1807048A1 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 07/18/2007 | EP1807047A2 Sodium ascorbate solubilisate |
| 07/18/2007 | EP1807046A2 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof |
| 07/18/2007 | EP1807040A1 Additional improvements in powder compaction and enrobing |
| 07/18/2007 | EP1807018A2 In situ controlled release drug delivery system |
| 07/18/2007 | EP1806980A1 Thermally stable, high tensile strength encapsulated actives |
| 07/18/2007 | EP1526848B1 Opioid-receptor antagonists in transdermal systems having buprenorphine |
| 07/18/2007 | EP1503722B1 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 07/18/2007 | EP1383482B1 Method for manufacturing a low dose pharmaceutical composition |
| 07/18/2007 | EP1278513B1 A core formulation |
| 07/18/2007 | EP1178780B1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 07/18/2007 | EP1143938B1 Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids |
| 07/18/2007 | EP1139753B1 Formulations for treating disease and methods of using same |
| 07/18/2007 | EP0943327B1 Medicinal composition |
| 07/18/2007 | EP0859751B2 Semi-fluorinated alkanes and their use |
| 07/18/2007 | EP0840623B1 Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles |
| 07/18/2007 | EP0770140B1 Composition containing nucleic acids and cationic polymers, preparation and uses |
| 07/18/2007 | CN1326929C The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use |
| 07/18/2007 | CN1326569C Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/18/2007 | CN1326567C Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
| 07/18/2007 | CN1326555C Chinese medicinal powder preparation for treating hepatic ascites |
| 07/18/2007 | CN1326551C Therapy assisting agent for malignancy and its preparation method |
| 07/18/2007 | CN1326548C Medicine for treating gonorrhoea |
| 07/18/2007 | CN1326547C Chinese medicine composition for treating coronary heart disease and and method for preparing the same |
| 07/18/2007 | CN1326545C Water expelling swell dispersing pill |
| 07/18/2007 | CN1326543C Fracture, bone-recovering Chinese medicine soft capsule |
| 07/18/2007 | CN1326542C Fracture, bone-recovering Chinese medicine guttate pills |